Sowell Financial Services LLC Allogene Therapeutics, Inc. Transaction History

Sowell Financial Services LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 05, 2021	SELL	$23.49 - $35.8 $67,110 - $102,280	-2,857 Closed	0 $0
Q1 2021 May 07, 2021	SELL	$25.79 - $39.02 $21,792 - $32,971	-845 Reduced 22.83%	2,857 $83,000
Q4 2020 Jan 13, 2021	BUY	$25.24 - $43.45 $93,438 - $160,851	3,702 New	3,702 $93,000
Q3 2020 Nov 12, 2020	SELL	$32.38 - $44.96 $518 - $719	-16 Closed	0 $0
Q2 2020 Aug 13, 2020	SELL	$18.39 - $54.04 $23,171 - $68,090	-1,260 Reduced 98.75%	16 $1,000
Q1 2020 May 12, 2020	SELL	$18.22 - $28.25 $11,952 - $18,532	-656 Reduced 33.95%	1,276 $25,000
Q4 2019 Feb 07, 2020	BUY	$24.82 - $31.4 $47,952 - $60,664	1,932 New	1,932 $50,000

162

134M

59.4K

113K

Ticker ALLO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 143,807,008
Market Cap $360M
Description
Allogene Therapeutics, Inc., a clinical stage immuno-oncology company, develops and commercializes genetically engineered allogeneic T cell therapies for the treatment of cancer. It develops, manufactures, and commercializes UCART19, an allogeneic chimeric antigen receptor (CAR) T cell product candidate for the treatment of pediatric and adult p...

Get notified when there are updates to the investment portfolio of Sowell Financial Services LLC, based on Form 13F filings with the SEC.

Stay updated on Sowell Financial Services LLC with notifications on news.